What is the current Community Oncology Service market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Community Oncology Service market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Community Oncology Service market?

Increasing cancer incidence and technological advancements are key drivers.

What are the major challenges faced by the Community Oncology Service market?

High treatment costs and limited access to care are significant challenges.

Which regions are leaders in the Community Oncology Service market?

North America and Europe are currently leading regional markets.

Who are the top companies in the Community Oncology Service market?

Major players include Pfizer, Roche, and Johnson & Johnson.

What are the future opportunities in the Community Oncology Service market?

Personalized medicine and immunotherapy offer significant future opportunities.

How is technology impacting the Community Oncology Service market?

Technology is improving treatment outcomes and patient engagement.

What is the current regulatory landscape for the Community Oncology Service market?

Regulations focus on patient safety, data privacy, and treatment accessibility.

What is the future outlook for the Community Oncology Service market?

The future outlook is positive, driven by innovation and increasing demand.

Community Oncology Service Value Chain Analysis & Forecast Outlook 2033

Community Oncology Service by Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), by Application (Breast Cancer, Lung Cancer, Liver Cancer, Kidney Cancer, Ovarian Cancer, Skin Cancer, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12345.6 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12345.6 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Community Oncology Service Market Size | CAGR 0.065 Forecast 2033

Community Oncology Service Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12345.6 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12345.6 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Community Oncology Service Market Overview

The Community Oncology Service market refers to the delivery of cancer care services in community-based settings, providing patients with accessible and affordable treatment options. As the Community Oncology Service market size is estimated to be approximately $12.8 billion in 2025, the growth outlook and market forecast indicate a promising future, with the industry expected to expand significantly over the forecast period. The market forecast suggests a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033, driven by macro drivers such as an increasing cancer incidence rate, an aging population, and advancements in cancer treatments. Key forces shaping the industry include technology shifts towards personalized medicine, regulations supporting community-based care, and consumer behavior prioritizing convenient and cost-effective services.

Loading chart…

The largest region in the Community Oncology Service market is North America, accounting for approximately 40% of the global market share, while the fastest-growing region is expected to be the Asia-Pacific, driven by increasing healthcare expenditure and a rising demand for cancer care services. The industry's expansion will be influenced by factors such as competitive intensity, supply-chain dynamics, and regulatory frameworks, making it essential for stakeholders to stay informed about the latest trends and developments in the Community Oncology Service market.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.41 billion
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Community Care Physicians PC; Nebraska Cancer Specialists; US Oncology; Tufts Medical Center; Doctors Medical Center; Oncology Specialists; Baptist Cancer Center
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Community Oncology Service market is poised for significant growth, driven by factors such as an increasing patient population and advancements in cancer treatment technologies. As the Community Oncology Service market size continues to expand, it is essential for stakeholders to understand the underlying market dynamics.

Growth Drivers2 items

Advancements in cancer treatment technologies, such as immunotherapy and targeted therapy, are driving the growth of the Community Oncology Service market, with a growth forecast indicating a significant increase in market size over the next five years.

The rising prevalence of cancer, coupled with an aging population, is fueling the demand for community oncology services, leading to an expansion of the Community Oncology Service market.

Restraints2 items

High operating costs, including the expense of purchasing and maintaining advanced medical equipment, are a significant restraint on the growth of the Community Oncology Service market, affecting the overall growth forecast.

The shortage of skilled healthcare professionals, particularly oncologists, is limiting the ability of community oncology services to meet the growing demand for cancer treatment, thereby impacting the Community Oncology Service market size.

Opportunities2 items

The integration of telemedicine and digital health technologies is creating new opportunities for community oncology services to expand their reach and improve patient outcomes, driving growth in the Community Oncology Service market.

The increasing focus on value-based care is driving the adoption of community oncology services, as they offer a cost-effective and high-quality alternative to traditional cancer treatment settings, contributing to the growth of the Community Oncology Service market size.

Challenges2 items

The complex regulatory landscape, including reimbursement policies and accreditation standards, poses a significant challenge to community oncology services, affecting their ability to operate efficiently and impacting the Community Oncology Service market.

The need to stay up-to-date with the latest advancements in cancer treatment and technology is a significant challenge for community oncology services, requiring ongoing investment in staff training and equipment upgrades to remain competitive in the Community Oncology Service market.

Market Segmentation

Loading chart…

The Type segmentation in the Community Oncology Service market refers to the different types of cancer treatments and services offered. This segment is crucial in understanding the Community Oncology Service segmentation and its impact on the overall market size. The type segment includes various subtypes, such as chemotherapy, radiation therapy, and immunotherapy, each contributing to the market's growth.

The Application segmentation in the Community Oncology Service market involves the different areas where these services are applied, such as hospitals, clinics, and research institutions. This segment plays a significant role in determining the market taxonomy and size. The application segment includes subtypes like breast cancer, lung cancer, and colorectal cancer, among others, each with its own set of requirements and challenges.

Community Oncology Service Segmentation Breakdown12 items

Type

Small Community Oncology Clinics

Medium Community Oncology Clinics

Large Community Oncology Clinics

Application

Breast Cancer

Lung Cancer

Liver Cancer

Kidney Cancer

Ovarian Cancer

Skin Cancer

Others

Regional Insights

Loading chart…

The Community Oncology Service market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of community oncology services, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting community oncology, a strong ecosystem, and growing adoption. Asia Pacific's growth is fueled by increasing investments, a rising demographics demand, and improving infrastructure. Latin America's growth is driven by emerging ecosystems, while the Middle East & Africa region is expected to grow due to increasing adoption and investments.

The regional forecast indicates that Asia Pacific will experience the highest Community Oncology Service market growth, driven by its large and growing population, increasing demographics awareness, and policies supporting community oncology services. As the market continues to evolve, understanding the unique drivers and challenges of each region will be crucial for stakeholders to navigate the regional forecast and capitalize on emerging opportunities.

Competitive Landscape

The Community Oncology Service market is moderately consolidated, driven by a mix of global players and local/regional companies. The Community Oncology Service competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in this market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, expansion, research and development, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages.

Community Care Physicians PC: regional expansion

Nebraska Cancer Specialists: vertical integration

US Oncology: premium pricing

Tufts Medical Center: innovation pipeline

Doctors Medical Center: local manufacturing

Oncology Specialists: OEM tie-ups

Key Community Oncology Service Companies7 items

Community Care Physicians PC

Nebraska Cancer Specialists

US Oncology

Tufts Medical Center

Doctors Medical Center

Oncology Specialists

Baptist Cancer Center

Market Ecosystem

The Community Oncology Service ecosystem spans upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the delivery of cancer treatment services, with various participants contributing to the overall ecosystem. The ecosystem boundaries are defined by the interactions between these participants, influencing how value flows and is captured.

Technology providers — supplying medical equipment and software

Oncology specialists — delivering cancer treatment services

Hospitals/clinics — providing facilities for treatment

Pharmaceutical companies — supplying cancer medications

Distributors/channel partners — facilitating access to treatments

Regulators/standards bodies — setting treatment guidelines and standards

Financing/leasing partners — supporting funding for treatments and equipment

In the Community Oncology Service ecosystem, control points are primarily held by regulators and payers, influencing adoption through reimbursement policies and treatment guidelines. Dependency risks arise from input constraints, such as limited access to certain medications or equipment, as well as standards and approvals from regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem, with varying degrees of interoperability required between different treatment services and technologies. Furthermore, the ecosystem may differ by region due to diverse regulatory environments and access to treatments.

Recent Industry Insights

The Community Oncology Service industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have enabled the integration of innovative technologies, such as artificial intelligence and data analytics, to enhance cancer treatment outcomes. Notable mergers and acquisitions have also led to the expansion of community oncology services, providing patients with increased access to specialized care. Furthermore, product launches and technological advancements have improved the efficiency and effectiveness of cancer treatments. Regulatory changes have focused on promoting value-based care, and there has been a shift in consumer trends towards personalized medicine. Additionally, funding rounds and expansions have supported the growth of community oncology services, driving innovation and improvement in patient care.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Community Oncology Service market. The market attractiveness is moderate, driven by the increasing demand for cancer treatments and the need for cost-effective services. The competitive intensity is high, with numerous players competing for market share. The long-term outlook for the Community Oncology Service market outlook is positive, with opportunities for growth and innovation. The innovation landscape is evolving, with a focus on personalized medicine and digital health. However, the demand–supply balance is a concern, with a shortage of skilled professionals in some areas. Key risk factors include regulatory changes and reimbursement pressures.

11 items

1. Executive Summary

2. Community Oncology Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Community Oncology Service Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Community Oncology Service Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Small Community Oncology Clinics

6.1.2. Medium Community Oncology Clinics

6.1.3. Large Community Oncology Clinics

6.2. Global Community Oncology Service Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Breast Cancer

6.2.2. Lung Cancer

6.2.3. Liver Cancer

6.2.4. Kidney Cancer

6.2.5. Ovarian Cancer

6.2.6. Skin Cancer

6.2.7. Others

6.3. Global Community Oncology Service Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Community Oncology Service Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Community Oncology Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Community Oncology Service Market Competition by Key Manufacturers

8.1. Global Community Oncology Service Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Community Oncology Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Community Care Physicians PC

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Nebraska Cancer Specialists

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. US Oncology

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Tufts Medical Center

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Doctors Medical Center

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Oncology Specialists

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Baptist Cancer Center

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Community Oncology Service Market

Figure 4: Global Community Oncology Service Market: Drivers

Figure 5: Global Community Oncology Service Market: Challenges

Figure 6: Global Community Oncology Service Market: Trends

Figure 7: Global Community Oncology Service Market: Opportunity

Figure 8: Global Community Oncology Service Market: Restraint

Figure 9: Global Community Oncology Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Community Oncology Service Market Value (USD Million) By Region

Figure 15: Global Community Oncology Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Community Oncology Service Market Value (USD Million) By Region

Figure 23: Global Community Oncology Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Community Oncology Service Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Community Oncology Service Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Community Oncology Service Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Community Oncology Service Market Value (USD Million) By Region

Table 10: Global Community Oncology Service Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Community Oncology Service Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Community Oncology Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Community Oncology Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Community Care Physicians PC Basic Information And Sales Area

Table 31: Community Care Physicians PC. Products Portfolio

Table 32: Nebraska Cancer Specialists Basic Information And Sales Area

Table 33: Nebraska Cancer Specialists. Products Portfolio

Table 34: US Oncology Basic Information And Sales Area

Table 35: US Oncology. Products Portfolio

Table 36: Tufts Medical Center Basic Information And Sales Area

Table 37: Tufts Medical Center. Products Portfolio

Table 38: Doctors Medical Center Basic Information And Sales Area

Table 39: Doctors Medical Center. Products Portfolio

Table 40: Oncology Specialists Basic Information And Sales Area

Table 41: Oncology Specialists. Products Portfolio

Table 42: Baptist Cancer Center Basic Information And Sales Area

Table 43: Baptist Cancer Center. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Type

Table 45: Global Market Share (%) By Type (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Community Oncology Service Market Value (USD Million) By Region

Table 49: Global Community Oncology Service Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Type

Table 52: North America Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Community Oncology Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.41 billion
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Community Care Physicians PC; Nebraska Cancer Specialists; US Oncology; Tufts Medical Center; Doctors Medical Center; Oncology Specialists; Baptist Cancer Center
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options